A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy

Abbreviated Name
PCGEM1 and PCA3 noncoding RNAs
Lead Investigator
Chesnut, GregoryCenter for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center
Coordinating Investigator
Chesnut, Gregory Center for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center
Involved Investigators

Abstract

No abstract availalbe.

Aims

1. To present the development and optimization of a noninvasive, first catch, nonDRE urine based sensitive gene expression assay 2. To define a CaP gene panel that can discriminate GS 7-10 from GS 6 (3D3) and benign disease before biopsy; IRB #WU IRB No. 11-7487

Analytic Method

ddPCR

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
 Team Project
Protocol ID
484
Protocol Type
Single
Fields of Research
  • Genomics
Collaborative Group
Prostate and Urologic Cancers Research Group
Cancer Types
  • Malignant neoplasm of prostate
Phased Status
2

Associated Forms